#GLP1 #PeptideTherapy #CravingControl #InsulinSupport #PrivatePractice To view or add a comment, sign in Findings from our new study support the real-world effectiveness and safety of direct-acting oral anticoagulants (DOACs) use among individuals with atrial fibrillation
Wegovy injection is approved alongside diet and exercise to reduce excess body weight in adults and in children aged 12 and older with obesity, to lower the risk of serious heart events (heart attack, stroke, or cardiovascular death) in adults with obesity or overweight who also have established heart disease, and for treatment of a liver condition called MASH (metabolic dysfunction-associated steatohepatitis, formerly called NASH) with moderate-to-advanced scarring in adults
Figure 3 presents the results of our Mitostress test assay
With our support, individuals in locations across the nation are equipped to make empowered choices that contribute to their weight loss journey
For these reasons, we recommend keeping alcohol intake minimal or avoiding it entirely during treatment